Pictet Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.2M Sell
124,701
-1,540
-1% -$571K 0.05% 347
2026
Q1
$37M Sell
126,241
-2,919
-2% -$959K 0.04% 373
2025
Q4
$45.3M Sell
129,160
-25,011
-16% -$8.45M 0.04% 349
2025
Q3
$49.8M Sell
154,171
-29,830
-16% -$9.28M 0.05% 328
2025
Q2
$71.6M Buy
184,001
+46,820
+34% +$18.8M 0.07% 250
2025
Q1
$59.7M Sell
137,181
-3,125
-2% -$1.25M 0.07% 281
2024
Q4
$51.8M Sell
140,306
-83,824
-37% -$35.1M 0.06% 290
2024
Q3
$117M Buy
224,130
+2,264
+1% +$1.21M 0.13% 181
2024
Q2
$120M Buy
221,866
+5,663
+3% +$2.99M 0.14% 171
2024
Q1
$112M Buy
216,203
+31,912
+17% +$15.9M 0.12% 192
2023
Q4
$86.9M Buy
184,291
+3,672
+2% +$1.7M 0.1% 220
2023
Q3
$78.6M Buy
+180,619
New +$81.9M 0.1% 223

Other funds holding ELV

Pictet Asset Management's ELV Position: Q2 2026 in Review

Pictet Asset Management reduced its Elevance Health (ELV) stake by 1.2% in Q2 2026, selling an estimated $571K and leaving 124,701 shares worth $48.2M. The position accounts for 0.05% of the portfolio, ranked #347.

Pictet Asset Management first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. The position peaked at $120M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Pictet Asset Management held 124,701 shares of Elevance Health worth $48.2M as of Q2 2026.
  • Pictet Asset Management sold 1,540 Elevance Health shares in Q2 2026, an estimated $571K.
  • Elevance Health made up 0.05% of Pictet Asset Management's portfolio in Q2 2026, its #347 holding.
  • Pictet Asset Management first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Elevance Health position peaked at $120M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.